ATARA BIOTHERAPEUTICS INC (ATRA)       3.78  +0.15 (+4.13%)

3.78  +0.15 (+4.13%)

US0465131078 - Common Stock - After market: 3.82 +0.04 (+1.06%)

Buy % Consensus

74
Analysts have set a mean price target of 19.16. This target is 406.96% above the current price.
ATRA was analyzed by 16 analysts. The buy percentage consensus is at 74. So analysts seem to be have mildly positive about ATRA.
In the previous month the buy percentage consensus was at a similar level.
ATRA was analyzed by 16 analysts, which is quite many. So the average rating should be quite meaningful.

Price Target

Price Low Median Mean High 3.783.0314.9419.1652.50 - -19.84% 295.32% 406.96% 1,288.89%

Up and Down Grades

Date Firm Action Rating
2022-08-16 Mizuho Maintains Buy
2022-08-09 Goldman Sachs Maintains Sell
2022-07-20 Citigroup Downgrade Neutral -> Sell
2022-07-13 Stifel Downgrade Buy -> Hold
2022-07-13 JP Morgan Downgrade Overweight -> Neutral
2022-05-24 Goldman Sachs Maintains Sell
2022-05-23 HC Wainwright & Co. Maintains Buy
2022-05-10 Citigroup Downgrade Buy -> Neutral
2022-01-03 JP Morgan Maintains Overweight
2021-05-13 JP Morgan Upgrade Neutral -> Overweight
2021-05-05 HC Wainwright & Co. Maintains Buy

Analyst Ratings Stock Screener Links

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA